Fierce Biotech July 26, 2022
Conor Hale

“You can’t get away from yourself by moving from one place to another,” Ernest Hemingway wrote nearly a century ago in his book “The Sun Also Rises,” as two men consider jumping continents to escape their troubles. In this digital century, where you can post from nearly anywhere, that phrase could be updated to: “You can’t escape your own personal brand.”

But in Martin Shkreli’s case, it appears he doesn’t even want to try. Two months fresh out of prison—and despite a federal judge banning the famous “pharma bro” from working in the drug industry for the rest of his life—he’s looking to get right back in the mix, and this time he’s hyping the blockchain.
...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Blockchain, Pharma, Pharma / Biotech, Technology
mRNA Vaccine Shows Promise In Pancreatic Cancer Trial
Hims & Hers vs. Novo Nordisk: Are Compounded GLP-1s Safe?
Community Pharmacists as Experts on Complex Patient Encounters
On Heels of FDA Nod, BridgeBio’s Rival to Blockbuster Pfizer Drug Wins European Approval
The First Diagnostic Immunome

Share This Article